Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://hassanqjpy188902.ssnblog.com/37755049/trelaglutide-exploring-a-new-option-for-chronic-diseases